Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats (Q44183029)

30 November 2017

Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats (English)

1 reference

30 November 2017

0 references

pulmonary hypertension

1 reference

Yasuhiro Ikeda

1

1 reference

30 November 2017

Yoshikazu Yonemitsu

2

1 reference

30 November 2017

Chu Kataoka

3

1 reference

30 November 2017

Shiro Kitamoto

4

1 reference

30 November 2017

Terutoshi Yamaoka

5

1 reference

30 November 2017

Ken-Ichi Nishida

6

1 reference

30 November 2017

Akira Takeshita

7

1 reference

30 November 2017

Kensuke Egashira

8

1 reference

30 November 2017

Katsuo Sueishi

9

1 reference

30 November 2017

1 November 2002

1 reference

American Journal of Physiology Heart and Circulatory Physiology

30 November 2017

1 reference

30 November 2017

283

1 reference

30 November 2017

5

1 reference

30 November 2017

H2021-8

1 reference

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

30 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

Gene transfer into muscle by electroporation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

Macrophage-derived growth factors in wound healing: regulation of growth factor production by the oxygen microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

Primary pulmonary hypertension. A national prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

Biology of the rantes/sis cytokine family

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

The impact of bronchiolitis obliterans on late morbidity and mortality after single and bilateral lung transplantation for pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

The use of single-nucleotide polymorphism maps in pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00919.2001

10.1152/AJPHEART.00919.2001

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference